Table II.
Comparison of post-vaccination acute side effects with age and gender.
| Post-vaccination side effects | Mean Age | P | Gender | P | History of COVID infection | P | ||
|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
| Male | Female | Yes | No | |||||
| Soreness/Redness | ||||||||
| • Yes (n=56) | 34.8±6.3 | 0.063 | 16 (28.6%) | 40 (71.4%) | 0.011* | 16 (28.6%) | 40 (71.4%) | 0.045 |
| • No (n=149) | 32.5±8.2 | 72 (48.3%) | 77 (51.7%) | 24 (16.1%) | 125 (83.9%) | |||
| Fever | ||||||||
| • Yes (n=69) | 34.5±5.1 | 0.072 | 26 (37.7%) | 43 (62.3%) | 0.280 | 20 (29.0%) | 49 (71.0%) | 0.015 |
| • No (n=136) | 32.4±8.8 | 62 (45.6%) | 74 (54.4%) | 20 (14.7%) | 116 (85.3%) | |||
| Chills/Rigor | ||||||||
| • Yes (n=42) | 33.5±6.1 | 0.689 | 14 (33.3%) | 28 (66.7%) | 0.159 | 12 (28.6%) | 30 (71.4%) | 0.097 |
| • No (n=155) | 33.0±8.2 | 74 (45.4%) | 89 (54.6%) | 28 (17.2%) | 135 (82.8%) | |||
| Headache | ||||||||
| • Yes (n=81) | 33.9±7.3 | 0.233 | 28 (34.6%) | 53 (65.4%) | 0.050* | 24 (29.6%) | 57 (70.4%) | 0.003 |
| • No (n=116) | 32.5±8.1 | 60 (48.4%) | 64 (51.6%) | 16 (12.9%) | 108 (87.1%) | |||
| Fatigue/Malaise | ||||||||
| • Yes (n=93) | 32.7±7.0 | 0.522 | 36 (38.7%) | 57 (61.3%) | 0.266 | 26 (28.0%) | 67 (72.0%) | 0.005 |
| • No (n=104) | 33.4±8.5 | 52 (46.4%) | 60 (53.6%) | 14 (12.5%) | 98 (87.5%) | |||
| GI disturbance | ||||||||
| • Yes (n=55) | 31.3±7.4 | 0.040* | 30 (54.5%) | 58 (38.7%) | 0.042* | 20 (36.4%) | 35 (63.6%) | <0.001 |
| • No (n=142) | 33.8±7.8 | 58 (38.7%) | 92 (61.3%) | 20 (13.3%) | 130 (86.7%) | |||
| Flu-like symptoms | ||||||||
| • Yes (n=28) | 36.1±6.4 | 0.030* | 12 (42.9%) | 16 (57.1%) | 0.994 | 0 (0%) | 28 (100%) | 0.005 |
| • No (n=169) | 32.6±7.9 | 76 (42.9%) | 101 (57%) | 40 (22.6%) | 137 (77.4%) | |||
*
Significant p-values.